LIPID NANOCARRIERS FOR TARGETING ORAL CANCER: AN UPDATED REVIEW
P. Glory Margaret, G. Sai Mahesh, M. Suraj Narayana, V. Sai Bhavana, M. Mohan Varma, P. V. Swamy and Ashok Thulluru*
ABSTRACT
In the medical sector, Drug delivery systems typically use nanotechnology, and pharmaceuticals have shown to have promising therapeutic efficacy. Nanocarriers transport information from the biological active moiety to achieve site specific action. This mode of delivery system lowers patient’s expenses on drugs and increase patient drug compliance. Drug carriers made of lipid nanoparticles have many advantages including high biodegradability and bio compatibility. Nanocarriers dependent on lipids tend to have the opportunity to effective method for overcoming the complexities of anticancer treatment taken orally with safety. Lipid nanocarriers and their distribution through the lymphatic mechanism to boost oral bioavailability of anticancer drugs will be addressed in this study.
Keywords: Nanotechnology, Nano carriers, Lipid nano carriers, Anti-cancer drugs.
[Download Article]
[Download Certifiate]